The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world biomarker testing patterns among patients with metastatic colorectal cancer (mCRC) treated with later lines of therapy (LOT) in the United States (US) community oncology setting.
 
Arvind Katta
Employment - Bayer HealthCare Pharmacuticals
 
Afsaneh Barzi
Leadership - Cardiff Oncology
Consulting or Advisory Role - Bayer Technology System; bioTheranostics; Daiichi Sankyo/Astra Zeneca; Merrion
Speakers' Bureau - Helsinn Therapeutics/QED Therapeutics
Research Funding - Bayer (Inst); Merck (Inst)
 
Brian Thomas Hocum
Employment - Bayer
 
Sreevalsa Appukkutan
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
David Cosgrove
Employment - Compass Oncology
Leadership - Compass Oncology; Sarah Cannon Research Institute
Honoraria - EMD Serono
Consulting or Advisory Role - Daiichi Sankyo/Lilly; Genentech; Merck KGaA
Travel, Accommodations, Expenses - US Oncology
 
Ila Sruti
Employment - Ontada/McKesson
 
Junxin Shi
Employment - Mckesson
 
Wei Dai
Employment - Ontada/McKesson
 
Gregory A. Patton
Employment - Northwest Cancer Specialists; Ontada/McKesson; Texas Oncology
Travel, Accommodations, Expenses - Northwest Cancer Specialists; Ontada/McKesson; Texas Oncology
 
Svetlana Babajanyan
Employment - Bayer
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Abbvie; Amgen (Inst); Arcus Biosciences (Inst); AstraZeneca; Bayer (Inst); BeiGene; Boehringer Ingelheim; Caladrius Biosciences; Caladrius Biosciences; Celularity; Daiichi Sankyo/UCB Japan; Deciphera; Eisai; Eisai; Exact Sciences; Foundation Medicine; Foundation Medicine; Illumina; Immuneering; Incyte (Inst); Ipsen (Inst); Janssen; Kanaph Therapeutics; Lilly (Inst); Natera; Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst); SOBI; Stemline Therapeutics; Treos Bio; Zai Lab
Patents, Royalties, Other Intellectual Property - Patent WO/2018/183488; Patent WO/2019/055687
Other Relationship - 1Globe Health Institute; AstraZeneca; Exelixis; FibroGen; Imugene; Lilly; Merck (Inst); Pancreatic Cancer Action Network; Replimune; Sun Biopharma; Suzhou Kintor Pharmaceuticals; UpToDate; Xilis